RxSight, Inc. (RXST): Price and Financial Metrics

RxSight, Inc. (RXST): $52.34

0.76 (+1.47%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

F

RXST Price/Volume Stats

Current price $52.34 52-week high $58.21
Prev. close $51.58 52-week low $17.09
Day low $50.71 Volume 270,100
Day high $52.90 Avg. volume 433,086
50-day MA $52.44 Dividend yield N/A
200-day MA $37.43 Market Cap 1.94B

RXST Stock Price Chart Interactive Chart >


RxSight, Inc. (RXST) Company Bio


RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.


RXST Latest News Stream


Event/Time News Detail
Loading, please wait...

RXST Latest Social Stream


Loading social stream, please wait...

View Full RXST Social Stream

Latest RXST News From Around the Web

Below are the latest news stories about RXSIGHT INC that investors may wish to consider to help them evaluate RXST as an investment opportunity.

RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

Yahoo | November 15, 2023

RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript

RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day, and thank you for standing by. Welcome to the RxSight Third Quarter 2023 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Alex […]

Yahoo | November 12, 2023

Here's Why We're Not Too Worried About RxSight's (NASDAQ:RXST) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Yahoo | November 11, 2023

Q3 2023 Rxsight Inc Earnings Call

Q3 2023 Rxsight Inc Earnings Call

Yahoo | November 10, 2023

RxSight, Inc. Reports Third Quarter 2023 Financial Results

ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three and nine months ended September 30, 2023. Key Quarterly Highlights Reported third quarter 2023 revenue of $22.2 million, an increase of 76% compared to the third quarter of 2022, reflecting: The sale of 66 Light Delivery Devices (LDD™s

Yahoo | November 9, 2023

Read More 'RXST' Stories Here

RXST Price Returns

1-mo 7.78%
3-mo 12.70%
6-mo 148.41%
1-year 197.89%
3-year N/A
5-year N/A
YTD 29.81%
2023 218.23%
2022 12.62%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!